Lotte Chemical Titan Holding Berhad Past Earnings Performance
Past criteria checks 0/6
Lotte Chemical Titan Holding Berhad's earnings have been declining at an average annual rate of -49.9%, while the Chemicals industry saw earnings growing at 7.7% annually. Revenues have been growing at an average rate of 1% per year.
Key information
-49.9%
Earnings growth rate
-49.9%
EPS growth rate
| Chemicals Industry Growth | 8.9% |
| Revenue growth rate | 1.0% |
| Return on equity | -5.0% |
| Net Margin | -9.7% |
| Last Earnings Update | 31 Mar 2024 |
Recent past performance updates
Recent updates
Lotte Chemical Titan Holding Berhad's (KLSE:LCTITAN) Shares Lagging The Industry But So Is The Business
Dec 26
Downgrade: Here's How Analysts See Lotte Chemical Titan Holding Berhad (KLSE:LCTITAN) Performing In The Near Term
Jul 30Be Wary Of Lotte Chemical Titan Holding Berhad (KLSE:LCTITAN) And Its Returns On Capital
Jul 22Capital Allocation Trends At Lotte Chemical Titan Holding Berhad (KLSE:LCTITAN) Aren't Ideal
Dec 29A Look At The Fair Value Of Lotte Chemical Titan Holding Berhad (KLSE:LCTITAN)
Nov 25When Should You Buy Lotte Chemical Titan Holding Berhad (KLSE:LCTITAN)?
Sep 30Here's What's Concerning About Lotte Chemical Titan Holding Berhad's (KLSE:LCTITAN) Returns On Capital
Aug 26Should You Think About Buying Lotte Chemical Titan Holding Berhad (KLSE:LCTITAN) Now?
Jun 06The Returns On Capital At Lotte Chemical Titan Holding Berhad (KLSE:LCTITAN) Don't Inspire Confidence
May 17Should You Think About Buying Lotte Chemical Titan Holding Berhad (KLSE:LCTITAN) Now?
Mar 01Zooming in on KLSE:LCTITAN's 2.5% Dividend Yield
Jan 18Does Lotte Chemical Titan Holding Berhad's (KLSE:LCTITAN) Statutory Profit Adequately Reflect Its Underlying Profit?
Dec 31If You Had Bought Lotte Chemical Titan Holding Berhad's (KLSE:LCTITAN) Shares Three Years Ago You Would Be Down 42%
Dec 14
Is Now An Opportune Moment To Examine Lotte Chemical Titan Holding Berhad (KLSE:LCTITAN)?
Nov 26Revenue & Expenses Breakdown
How Lotte Chemical Titan Holding Berhad makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Mar 24 | 7,593 | -734 | 240 | 0 |
| 31 Dec 23 | 7,646 | -780 | 242 | 0 |
| 30 Sep 23 | 7,858 | -927 | 237 | 0 |
| 30 Jun 23 | 8,272 | -1,227 | 245 | 0 |
| 31 Mar 23 | 9,231 | -1,060 | 231 | 0 |
| 31 Dec 22 | 10,019 | -731 | 223 | 0 |
| 30 Sep 22 | 10,636 | -229 | 258 | 0 |
| 30 Jun 22 | 10,498 | 176 | 264 | 0 |
| 31 Mar 22 | 10,223 | 704 | 253 | 0 |
| 31 Dec 21 | 9,831 | 1,040 | 248 | 0 |
| 30 Sep 21 | 9,069 | 1,022 | 247 | 0 |
| 30 Jun 21 | 8,773 | 1,052 | 235 | 0 |
| 31 Mar 21 | 7,807 | 759 | 227 | 0 |
| 31 Dec 20 | 6,901 | 149 | 211 | 0 |
| 30 Sep 20 | 6,953 | 185 | 190 | 0 |
| 30 Jun 20 | 7,179 | 198 | 202 | 0 |
| 31 Mar 20 | 7,730 | 214 | 216 | 0 |
| 31 Dec 19 | 8,438 | 440 | 234 | 0 |
| 30 Sep 19 | 8,801 | 259 | 237 | 0 |
| 30 Jun 19 | 9,052 | 385 | 223 | 0 |
| 31 Mar 19 | 9,200 | 595 | 201 | 0 |
| 31 Dec 18 | 9,245 | 783 | 181 | 0 |
| 30 Sep 18 | 9,025 | 1,154 | 181 | 0 |
| 30 Jun 18 | 8,623 | 1,168 | 182 | 0 |
| 31 Mar 18 | 8,124 | 966 | 182 | 0 |
| 31 Dec 17 | 7,824 | 1,064 | 187 | 0 |
| 30 Sep 17 | 7,853 | 977 | 187 | 0 |
| 30 Jun 17 | 7,842 | 1,095 | 183 | 0 |
| 31 Mar 17 | 8,066 | 1,385 | 189 | 0 |
| 31 Dec 16 | 8,137 | 1,315 | 190 | 0 |
| 31 Dec 15 | 8,148 | 613 | 194 | 0 |
| 31 Dec 14 | 8,611 | -19 | 179 | 0 |
Quality Earnings: LCTITAN is currently unprofitable.
Growing Profit Margin: LCTITAN is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: LCTITAN is unprofitable, and losses have increased over the past 5 years at a rate of 49.9% per year.
Accelerating Growth: Unable to compare LCTITAN's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: LCTITAN is unprofitable, making it difficult to compare its past year earnings growth to the Chemicals industry (21.4%).
Return on Equity
High ROE: LCTITAN has a negative Return on Equity (-5.05%), as it is currently unprofitable.